PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27102553-1	2016	INTRODUCTION: This study aimed to evaluate whether the combination of erythropoietin (EPO) and tranexamic acid (TXA) exerted any additional benefits on the number of blood transfusions required and haematological parameters compared with TXA alone following primary bilateral simultaneous total hip arthroplasty.	Tranexamic Acid	238-241	erythropoietin	Homo sapiens	86-89	
27102553-8	2016	RESULTS: The total amount of blood transfusion and mean blood transfusion per patient was lower in group EPO + TXA than in group TXA (p = 0.039, p = 0.023; respectively).	Tranexamic Acid	111-114	erythropoietin	Homo sapiens	105-108	
21358317-3	2011	We hypothesized that intraoperative TXA would reduce blood transfusion relative to placebo in patients pretreated with erythropoietin.	Tranexamic Acid	36-39	erythropoietin	Homo sapiens	119-133